This text investigates the physiological impact of antipsychotic medications on patient metabolic health, specifically focusing on weight gain, glucose dysregulation, and lipid profile alterations. Meyer provides a comprehensive analysis of the pharmacological mechanisms that link dopamine and serotonin receptor antagonism to systemic metabolic side effects. The work synthesizes clinical data to offer a framework for monitoring and mitigating these risks in psychiatric practice.

Experts recognize this work as a critical reference for clinicians balancing psychiatric efficacy with physical health outcomes. Readers frequently note the clinical density of the prose, which serves as a standard resource for practitioners navigating the complexities of psychopharmacology.